Clinics Face Uncertainty as Title X Funding Deadline Approaches
For clinics dependent on federal Title X funding, April 1 marks a crucial date. This day typically sees an update to the annual funding for the grant program, which plays a vital role in delivering reproductive health services to millions of individuals.
Title X funds are crucial for clinics providing a wide array of reproductive health services, including contraception, cancer screenings, health examinations, and HIV testing, benefiting over 2.8 million people—many of whom are low-income, uninsured, or underinsured.
This year, however, the Trump administration has delayed the standard application process for new grants. As a result, many clinics are increasingly concerned about the availability of much-needed funds. Traditionally, the application window for Title X grants opens in the fall, allowing clinics several months to prepare. In contrast, the Department of Health and Human Services (HHS) began accepting applications on March 13, providing clinics with just one week to apply.
Many clinics plan to rely on funding from the previous year. However, they may also seek government permission to carry over any remaining funds. Claire Coleman, CEO of the National Family Planning and Reproductive Health Association, remarked on the unprecedented short timeframe between the application deadline and the funding deadline.
As the clock ticks down, Coleman noted that no clinics had yet been awarded the annual funding by Tuesday afternoon. The typical review period for grant applications spans 70 to 90 days, making this year’s expedited process particularly alarming.
The HHS spokesperson Andrew Nixon did not respond to inquiries about whether Title X funds would be distributed on schedule. Instead, he issued a statement regarding next year’s grant application process, indicating that HHS will issue a new Notice of Funding Opportunity (NOFO) for Title X programs that align with the agency’s priorities.
Diverse Impacts on Clinics
While HHS has the option to reimburse clinics for costs incurred during the waiting period, this has not been confirmed. Coleman said the lack of decision on reimbursement adds to the uncertainty for many clinics. The Title X program, originally enacted in 1970 under bipartisan support from President Richard Nixon, aimed to reduce unintended pregnancies by providing accessible contraception. Today, its services have expanded to include fertility treatments, cancer screenings, and sexually transmitted disease testing and treatment.
The sliding scale fee structure in place allows clinics to serve families based on income levels. Families earning below 100% of the federal poverty level are eligible for free care. Federal law mandates that clinics cannot deny treatment to those who are unable to pay.
Brian Hale, CEO of Neighborhood Health Network in Nashville, Tennessee, is currently devising contingency plans for his 12 clinics in anticipation of potential funding shortfalls. With demand for Title X services on the rise, particularly as premium increases have driven some individuals to opt out of Affordable Care Act plans, Hale is exploring ways to manage operational costs without drastically affecting services.
While some clinics are concerned about imminent funding cuts, others remain hopeful that they will continue to provide necessary services despite delays. Ruth Richardson, CEO of Planned Parenthood North Central States, emphasized that her organization intends to keep Title X services as affordable as possible, sustaining low or no-cost care for clients.
Struggles and History of Title X Funding
Confusion surrounding Title X funding is not a novel issue. Last year, the Trump administration suspended funds for approximately a quarter of Title X grants, which impacted an estimated 842,000 patients. HHS eventually restored the funds after a lawsuit challenged the freeze, leading to a reinstatement in December. Although President Trump initially proposed eliminating the entire $286 million allocated for the Title X program in his 2026 budget request, Congress succeeded in including it in the funding bill passed earlier this year.
As Richardson eloquently put it, investing in Title X services is not only a moral imperative but also a cost-effective strategy. “These are essential health services that people need,” she remarked. “Investing aggressively in Title X programs is far more economical than addressing the downstream consequences of lack of access.”
HHS awarded five-year grants in 2022 to support over 4,000 clinics entering the final year of their grant cycle. However, Title X recipients are required to reapply for funding annually. During the Trump administration, a significant regulation barred Title X clinics from providing abortion care or referrals, resulting in approximately 1,000 clinics withdrawing from the program. This regulation has since been repealed under the Biden administration, although the Trump administration has yet to revisit it.
Despite the political volatility surrounding Title X, Coleman remains optimistic about the program’s longevity, asserting that it has faced challenges for over a decade but has continuously found ways to persevere. “While the funding battles will likely continue, I believe this program is vital and will endure,” she said.
